Stocks-BMRN-BioMarin Pharmaceutical Inc

BMRN BioMarin Pharmaceutical Inc

90.11 0.03 (0.03%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest

FINANCIAL SUMMARY

For the quarter ended 31/12/2022, BioMarin Pharmaceutical Inc's revenues increased by 6.37% and amounted to 537.54M. Net income increased by 96.26% to -249.00K. Net assets increased by 0.76% to 4.60B and EPS increased from -0.04 to 0.00.
BMRN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
73.31%
Net Profit Margin
8.70%
Operating Margin
0.50%
Return On Investment
3.01%